Loading…
Hope Botanicals, LLC was cited for selling unapproved new drugs in the form of CBD products for both animals and humans without FDA approval, violating sections 505(a) and 512(a) of the Federal Food, Drug, and Cosmetic Act. The company's animal products, including "CBD Horse Pellets" and "Happy Horse Bites," were deemed unsafe unapproved new animal drugs, while human products such as "Broad Spectrum Tincture" and "CBD Gel Caps" were sold as unapproved new drugs and found to be misbranded under section 502(f)(1) of the FD&C Act. The violations were discovered during an FDA review of the company's website and social media platforms (Facebook and Instagram) in May 2022, where therapeutic claims for the CBD products were being made to consumers.